<DOC>
	<DOC>NCT00406653</DOC>
	<brief_summary>The purpose of this clinical research study is to learn if abatacept can improve signs and symptoms of active Crohn's Disease in patients who have not had an adequate response to other therapies. The safety of this treatment will also be studied.</brief_summary>
	<brief_title>A Study of Abatacept in Patients With Active Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>18 years or older have had Crohn's Disease for at least 3 months moderate to severely active Crohn's Disease have had an inadequate response or intolerance to other Crohn's Disease treatments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>